These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18569774)

  • 61. Glaucoma costs in Denmark in treatment naive patients.
    Olsen J; Berdeaux G; Skov J
    Acta Ophthalmol; 2013 Feb; 91(1):25-31. PubMed ID: 21834919
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Economic burden of knee and hip osteoarthritis in Spain.
    Loza E; Lopez-Gomez JM; Abasolo L; Maese J; Carmona L; Batlle-Gualda E;
    Arthritis Rheum; 2009 Feb; 61(2):158-65. PubMed ID: 19177521
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Economic burden of cancer in South Korea for the year 2005].
    Kim J; Hahm MI; Park EC; Park JH; Park JH; Kim SE; Kim SG
    J Prev Med Public Health; 2009 May; 42(3):190-8. PubMed ID: 19491563
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Hwang WW; Li TK; Lee KK; Li EK
    Rheumatology (Oxford); 2008 Sep; 47(9):1422-5. PubMed ID: 18635597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acute treatment costs of stroke in Brazil.
    Christensen MC; Valiente R; Sampaio Silva G; Lee WC; Dutcher S; Guimarães Rocha MS; Massaro A
    Neuroepidemiology; 2009; 32(2):142-9. PubMed ID: 19088487
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Costs of heart disease and risk behaviour: implications for expenditure on prevention.
    Kruse M; Davidsen M; Madsen M; Gyrd-Hansen D; Sørensen J
    Scand J Public Health; 2008 Nov; 36(8):850-6. PubMed ID: 19004902
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pilot study: tobacco-attributable direct costs in two hospitals in Santiago, Chile].
    Martínez-Gutiérrez MS; Vanegas L J; Reveco U S; Valenzuela R R; Arteaga H O
    Rev Med Chil; 2008 Oct; 136(10):1281-7. PubMed ID: 19194624
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The cost of systemic sclerosis.
    Bernatsky S; Hudson M; Panopalis P; Clarke AE; Pope J; Leclercq S; St Pierre Y; Baron M;
    Arthritis Rheum; 2009 Jan; 61(1):119-23. PubMed ID: 19116974
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An estimate of the total worldwide societal costs of dementia in 2005.
    Wimo A; Winblad B; Jönsson L
    Alzheimers Dement; 2007 Apr; 3(2):81-91. PubMed ID: 19595921
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cost of disorders of the brain in Spain.
    Parés-Badell O; Barbaglia G; Jerinic P; Gustavsson A; Salvador-Carulla L; Alonso J
    PLoS One; 2014; 9(8):e105471. PubMed ID: 25133395
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The size, burden and cost of disorders of the brain in the UK.
    Fineberg NA; Haddad PM; Carpenter L; Gannon B; Sharpe R; Young AH; Joyce E; Rowe J; Wellsted D; Nutt DJ; Sahakian BJ
    J Psychopharmacol; 2013 Sep; 27(9):761-70. PubMed ID: 23884863
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correlates of use of health care services by children and adolescents from 11 European countries.
    Berra S; Tebé C; Erhart M; Ravens-Sieberer U; Auquier P; Detmar S; Herdman M; Alonso J; Rajmil L;
    Med Care; 2009 Feb; 47(2):161-7. PubMed ID: 19169116
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The economic burden of mental disorders in China, 2005-2013: implications for health policy.
    Xu J; Wang J; Wimo A; Qiu C
    BMC Psychiatry; 2016 May; 16():137. PubMed ID: 27169936
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Incremental direct expenditure of treating asthma in the United States.
    Kamble S; Bharmal M
    J Asthma; 2009 Feb; 46(1):73-80. PubMed ID: 19191142
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Health and non-health care resources use in the management of adult outpatients with drug-resistant epilepsy in Spain: a cost-of-illness study (LINCE study).
    Sancho J; Peña P; Rufo M; Palacios G; Masramon X; Rejas J;
    Epilepsy Res; 2008 Oct; 81(2-3):176-87. PubMed ID: 18617369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.